Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Glaxosmithkline Biologicals S a patents

Recent patent applications related to Glaxosmithkline Biologicals S a. Glaxosmithkline Biologicals S a is listed as an Agent/Assignee. Note: Glaxosmithkline Biologicals S a may have other listings under different names/spellings. We're not affiliated with Glaxosmithkline Biologicals S a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Glaxosmithkline Biologicals S a-related inventors




Date Glaxosmithkline Biologicals S a patents (updated weekly) - BOOKMARK this page
07/27/17Immunogenic composition
07/13/17Novel method and compositions
05/04/17Saccharide vaccine formulation
04/27/17Novel methods for inducing an immune response
03/23/17Vaccine
03/16/17Method for inducing a trif-bias
03/09/17Novel compositions and methods
03/09/17Immunogenic composition
03/09/17Vaccine compositions comprising a saponin adjuvant
03/02/17Immunogenic composition for use in therapy
02/23/17Expression systems
02/02/17Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
09/29/16Method of treatment
09/15/16Salmonella conjugate vaccines
09/15/16Calcium fluoride compositions
09/01/16Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
08/25/16Vaccine comprising protein nmb0964 from neisseria meningitidis
08/25/16Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
08/18/16Calcium fluoride compositions
08/04/16Mycobacterium antigenic composition
08/04/16A chemically defined medium for the industrial scale culture of a species of bordetella
07/21/16Novel influenza antigens and antibodies
07/21/16Novel method
07/07/16Combination immunogenic compositions
06/30/16Novel compositions and methods
06/23/16Vaccine composition
06/09/16Nucleotide sequences, vectors and host cells
05/19/16Gas57 mutant antigens and gas57 antibodies
05/12/16Method for determining the endotoxin content of an aluminum salt preparation
05/12/16Immunogenic composition for use in therapy
05/05/16Recombinant rsv antigens
04/21/16Novel process
03/24/16Neisserial vaccine compositions comprising a combination of antigens
03/10/16Mutant bacteria for production of generalized modules for mrmbrane antigens
01/28/16Composition for buffered aminoalkyl glucosaminide phosphate compounds and its use for enhancing an immune response
01/28/16Vaccine
12/17/15Vaccine comprising an oil in water emulsion
11/19/15Immunogenic composition for use in vaccination against staphylococcei
11/05/15Immunogenic composition
11/05/15Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins
10/01/15Vaccine
09/24/15Pneumoccal polysacchride conjugate vaccine
07/30/15Novel process
07/23/15Method for eliciting in infants an immune response against rsv and b. pertussis
07/09/15Pneumococcal capsular saccharide conjugate vaccine
06/25/15Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
06/18/15Use of alpha-toxin for treating and preventing staphylococcus infections
06/18/15Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
06/18/15Fermentation process
06/18/15Recombinant rsv antigens
05/14/15Method for determining a concentration of a polysorbate species in a mixture
05/07/15Immunogenic composition
05/07/15Novel process
04/02/15Modified antigens
03/19/15Vaccine
03/19/15Vaccine
02/12/15Immunogenic composition
02/05/15Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines
01/08/15Fermentation process
01/01/15Method for inducing a trif-bias
10/30/14Lipidated imidazoquinoline derivatives
10/23/14Novel compositions and methods
08/28/14Novel vaccine
08/28/14Fermentation process for the production of diphtheria toxin
08/28/14Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
Patent Packs
08/21/14Hiv vaccine
07/24/14Treatment of streptococcal infections
07/24/14Novel method and compositions
07/10/14Stabilised vaccine composition
07/03/14Conjugation process of bacterial polysaccharides to carrier proteins
07/03/14Conjugation process of bacterial polysaccharides to carrier proteins
04/17/14Immunogenic composition
04/17/14Immunogenic composition
04/10/14Vaccine against streptococcus pneumoniae
04/03/14Immunogenic composition
03/27/14Tuberculosis rv2386c protein, compositions and uses thereof
03/13/14Vaccine against streptococcus pneumoniae
02/20/14Fermentation process
02/06/14Novel method
01/30/14Purification process
Patent Packs
12/26/13Conjugation process
10/31/13Mycobacterium antigenic composition
10/24/13Mycobacterium antigenic composition
10/24/13Vaccine
09/26/13Vaccine
08/29/13Immunogenic composition
08/22/13Immunogenic compositions and methods for treating nuerologic disorders
07/04/13Immunogenic composition
05/16/13Novel antigen binding proteins
04/18/13Process for removing adventitious agents during the production of a virus in cell culture
04/11/13Novel process
04/04/13Process for the preparation of o/w emulsion
03/28/13Novel process
03/14/13Novel process
12/27/12Novel compounds
09/27/12Treatment of infections
09/20/12Live attenuated rotavirus vaccine for oral administration
07/26/12Vaccine
07/26/12Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
04/19/12Immunogenic compositions having low sodium chloride concentration
03/29/12Animal-free cell culture method
03/22/12Casb7439 constructs
03/15/12Neisserial vaccine compositions comprising a combination of antigens
03/15/12Neisserial vaccine compositions comprising a combination of antigens
02/23/12Vaccine
02/16/12Outer membrane vesicles and uses thereof
02/16/12Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine
02/02/12Neisserial vaccine compositions comprising a combination of antigens
02/02/12Kits for one-dose intradermal delivery for non-live trivalent influenza vaccine
11/24/11Multivalent adjuvanted influenza virus compositions
Social Network Patent Pack
10/06/11Influenza vaccine
08/04/11Vaccine
08/04/11Vaccine against hpv
06/30/11Vaccine
06/02/11Basb 205 polypeptides and polynucleotides from haemophilus influenzae
05/26/11Novel use
05/05/11Vaccine against varicella zoster virus
02/24/11Vaccine against varicella zoster virus
02/10/11Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb-neisseria meningitidis
01/13/11Immunogenic composition
Patent Packs
11/11/10Molecular typing of neisseria strains by determining the presence of genes involved in lipooligosaccharide (los) biosynthesis
10/28/10Vaccines for malaria
09/23/10Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
08/12/10Novel compounds
08/05/10Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
07/22/10Basb082 polynucleotides
06/10/10Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
03/25/10Moraxella catarrhalis basb115 polypeptides
02/18/10Vaccine
01/28/10Immunogenic composition
07/02/09Methods and materials therefor
05/28/09Closure system and filling a vial
05/14/09Purification of hbv antigens for use in vaccines
05/07/09Vaccines comprising outer membrane vesicles from gram negative bacteria
03/26/09Composition







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Biologicals S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Biologicals S a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';